Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2025-12-26 @ 4:02 AM
Study NCT ID:
NCT01676818
Status:
COMPLETED
Last Update Posted:
2025-11-06
First Post:
2012-08-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer
Sponsor:
University of Southern California
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
5C-11-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |